Skip to main content
. 2017 Mar 2;28(6):1912–1923. doi: 10.1681/ASN.2016070797

Figure 1.

Figure 1.

Early occurence of preexisting anti-HLA DSA ABMR and superior graft survival compared with de novo anti-HLA DSA ABMR. (A) Cumulative incidence of onset ABMR according to the DSA characteristics (preexisting DSA versus de novo DSA). (B) Probability of graft survival on the basis of DSA characteristics. (C) Probability of graft survival according to the DSA characteristics and the presence or absence of cg lesions. cg+ve, cg-positive; cg-ve, cg-negative.